AKT agonists can effectively alleviate oxidative stress, elevated blood glucose levels, and insulin resistance, suggesting that part of the diabetes mechanism induced by microplastics might be related to AKT/GSK3β phosphorylation. Here, AKT1 is linked to diabetes mellitus.